Topical delivery of different acyclovir palmitate liposome formulations through rat skin in vitro

Pharmazie

Volumn 59, Issue 3, 2004, Pages 203-206

  Liu, Hui ^a   Pan, Wei San ^b   Tang, Ren ^a   Luo, Shun De ^c  

^a WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CHOLESTEROL; DIPALMITOYLPHOSPHATIDYLCHOLINE; LIPOSOME; PALMITIC ACID; PHOSPHATIDYLCHOLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG PENETRATION; LIPID BILAYER; LIPID COMPOSITION; MICROENCAPSULATION; NONHUMAN; NUDE MOUSE; PHASE TRANSITION; RAT; SKIN PENETRATION; SKIN PERMEABILITY;

ACYCLOVIR; ADMINISTRATION, TOPICAL; ALGORITHMS; ANIMALS; ANTIVIRAL AGENTS; CHEMISTRY, PHARMACEUTICAL; CHEMISTRY, PHYSICAL; LIPOSOMES; OINTMENTS; RATS; SKIN ABSORPTION;

EID: 1642304526     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bouwstra JA, Gooris GS, van der Spek JA, Bras W (1991) Structural investigations of human stratum comeum by small-angle X-ray scattering. J Invest Dermatol 97: 1005-1012.
2. Chen Y, Tang R, Liu H, Pen ZX, Ding MH (2000) Topical penetration test of acyclovir palmitate in vitro from liposomal gel. Chin J Hosp Pharm 20: 324-327.
3. Egbaria K, Ramachandran C, Kittayanond D, Weiner N (1990) Topical delivery of liposomally encapsulated interferon evaluated by in vitro diffusion studies. Antimicrob Agents Chemother 34: 107-110.
4. Egbaria K, Weiner N (1990) Liposomes as a topical drug delivery system. Adv Drug Deliver Rev 5: 287-300.
5. Kim C, Shim J, Han S, Chang I (2002) The skin-permeation-enhancing effect of phosphatidylcholine: caffeine as a model active ingredient. J Cosmet Sci 53: 363-374.
6. Kirjavainen M, Monkkonen J, Saukkosaari M, Valjakka-Koskela R, Kiesvaara J, Urtti A (1999) Phospholipids affect stratum comeum lipid bilayer fluidity and drug partitioning into the bilayers. J Control Release 58: 207-214.
7. Liu H, Chen Y, Wu HZ, Ding MH, Pen ZX (2000) Studies on the gel of acyclovir palmitate liposome. Chin Pharm J 35: 457-460.
8. Liu H, Tang R, He XX, Zhang Y (2002) The effects of liposomes formulation and preparing method on the stability of acyclovir palmitate liposomes. Acta Pharmaceutica Sinica 37: 563-566.
9. Schreier H, Bouwstra J (1994) Liposomes and niosomes as topical drug carriers-dermal and transdermal drug delivery. J Control Release 30: 1-15.
10. Schreier H, Gagne L, Bock T, Erdos GW, Druzgala P, Conary JT, Müller BW (1997) Physicochemical properties and in vitro toxicity of cationic liposome cDNA complexes. Pharm Acta Helv 72: 215-223.
11. Vutla NB, Betageri GV, Banga AK (1996) Transdermal iontophoretic delivery of enkephalin formulated in liposomes. J Pharm Sci 85: 5-8.
12. Wertz PW, Abraham W, Landmann L, Downing DT (1986) Preparation of liposomes from stratum comeum lipids. J Invest Dermatol 87: 582-584.
13. Zimmermann E, Müller RH (2001) Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle, (SLN) dispersions in artificial gastrointestinal media. Eur J Pharm Biopharm 52: 203-210.